New Horizon Medical Solutions has announced a strategic collaboration with Soring, the U.S. affiliate of Söring, for the sale of an ultrasonic wound debridement device designed to enhance wound treatment. The partnership aims to expand access to advanced technology that addresses significant gaps in wound care management.
The Söring Ultrasonic-Assisted Wound debridement system consists of an ultrasonic generator and instrument intended for debridement and wound cleansing of chronic and acute wounds. The device can remove fibrin tissues such as necroses, fibrin, scab, and pus while breaking up biofilms. It is designed to improve wound status and promote healing in conditions including diabetic foot syndrome, decubitus ulcers, burns, post-surgical wounds, and post-traumatic wounds.
Jeffrey Alan Niezgoda, MD, Chief Medical Officer of Kent Imaging and board member of NHMS, emphasized the clinical significance of this technology. "The use of SONOCA 185 and the UAW instruments for Ultrasonic Wound Debridement guided by SnapshotGLO and monitored by SnapshotNIR can significantly improve wound management and lead to better patient outcomes," Niezgoda stated. "These devices synergistically optimize wound bed preparation prior to CAMPs application."
Will Hall, CEO of New Horizon Medical Solutions, explained the broader implications of this collaboration. "This collaboration reflects our belief that the future of wound care lies in combining advanced technology with evidence-based clinical solutions," Hall said. "By bringing Söring's ultrasonic system into our portfolio, we're expanding access to innovative tools that address critical gaps in treatment while improving efficiency and outcomes across care settings."
The partnership represents a significant development in wound care technology with potential impacts on patient outcomes, healthcare efficiency, and treatment standardization. For more information about the companies involved, visit https://www.nhmedical.com. The ultrasonic technology addresses a persistent challenge in wound management by providing a method to effectively remove problematic tissues that impede healing processes.
This collaboration between NHMS and Soring brings together expertise in wound care solutions and ultrasonic medical technology. Söring, founded in 1985 and headquartered in Germany, specializes in ultrasonic tissue resection and ablation technologies used by healthcare professionals worldwide. The company focuses on making surgical procedures more efficient, safer, and easier to perform through intuitive user experience and direct service.
The availability of this ultrasonic wound debridement system through NHMS's distribution network could potentially transform wound care protocols in various clinical environments. By addressing the removal of fibrin tissues and biofilms that often complicate wound healing, the technology offers a targeted approach to wound bed preparation that may reduce healing times and improve overall treatment outcomes for patients with challenging wound conditions.
